Moreover, Schulmann et al., using qMSP, reported that hypermethylation of CDKN2A occurs at early stages of BE-associated neoplastic transformation and functions as a predictive marker of disease progression [131]. This evidence concerns the gene CDKN2A and Barrett esophagus.